Literature DB >> 25553153

Psychosocial mechanisms of the pain and quality of life relationship for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Adrijana Krsmanovic1, Dean A Tripp2, J Curtis Nickel3, Daniel A Shoskes4, Michel Pontari5, Mark S Litwin6, Mary F McNaughton-Collins7.   

Abstract

INTRODUCTION: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent, chronic pelvic pain condition largely unresponsive to medical interventions. Psychosocial risk factors are associated with poor outcomes in CP/CPPS, but have not been examined for their intervening roles between pain and reduced quality of life (QoL). This study aimed to determine if psychosocial risk factors (i.e., patient coping and catastrophizing) mediate the association between pain and QoL.
METHODS: Using a cross sectional design, 175 men with CP/CPPS (mean age 46.83; SD 10.86) were recruited from tertiary care urology clinics and completed questionnaires on demographics, pain, QoL, pain coping, depression, and catastrophizing. An exploratory factor analysis was conducted and aggregate factor scores were examined to improve the amount of meaningful measurement to be used in multiple mediations. The models specified multiple risk factors as mechanisms between pain and both physical and mental QoL as the primary outcome measurements.
RESULTS: Four aggregate psychosocial factor scores were produced from the psychosocial measures (i.e., illness and wellness-focused behavioural coping, depression and catastrophizing). Illness-focused coping partially mediated the relationship between pain and physical QoL. However, catastrophizing and illness-focused coping fully mediated the relation between pain and mental QoL, showing the association between pain and mental QoL was no longer significant when catastrophizing and illness-focused coping were in the model.
CONCLUSION: Psychosocial factors function as mechanisms between higher pain and they are associated diminished mental QoL. These results introduce illness-focused coping as an important biopsychosocial target in CP/CPPS management.

Entities:  

Year:  2014        PMID: 25553153      PMCID: PMC4277519          DOI: 10.5489/cuaj.2179

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  25 in total

1.  Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models.

Authors:  Kristopher J Preacher; Andrew F Hayes
Journal:  Behav Res Methods       Date:  2008-08

2.  Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Dean A Tripp; J Curtis Nickel; Yanlin Wang; Mark S Litwin; Mary McNaughton-Collins; J Richard Landis; Richard B Alexander; Anthony J Schaeffer; Michael P O'Leary; Michel A Pontari; Jackson E Fowler; Leroy M Nyberg; John W Kusek
Journal:  J Pain       Date:  2006-10       Impact factor: 5.820

3.  A feasibility trial of a cognitive-behavioural symptom management program for chronic pelvic pain for men with refractory chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Dean A Tripp; J Curtis Nickel; Laura Katz
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

4.  Sickness impact of chronic nonbacterial prostatitis and its correlates.

Authors:  K Wenninger; J R Heiman; I Rothman; J P Berghuis; R E Berger
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

5.  Coping with fibromialgia: usefulness of the Chronic Pain Coping Inventory-42.

Authors:  Javier Garcia-Campayo; Aida Pascual; Marta Alda; Monica Teresa Gonzalez Ramirez
Journal:  Pain       Date:  2007-04-02       Impact factor: 6.961

6.  Validation of the Chronic Pain Coping Inventory.

Authors:  H D Hadjistavropoulos; F K MacLeod; G J Asmundson
Journal:  Pain       Date:  1999-04       Impact factor: 6.961

7.  The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network.

Authors:  M S Litwin; M McNaughton-Collins; F J Fowler; J C Nickel; E A Calhoun; M A Pontari; R B Alexander; J T Farrar; M P O'Leary
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

Review 8.  Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis".

Authors:  J N Krieger; K J Egan; S O Ross; R Jacobs; R E Berger
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

Review 9.  Pain catastrophizing: a critical review.

Authors:  Phillip J Quartana; Claudia M Campbell; Robert R Edwards
Journal:  Expert Rev Neurother       Date:  2009-05       Impact factor: 4.618

10.  Prevalence, symptom impact and predictors of chronic prostatitis-like symptoms in Canadian males aged 16-19 years.

Authors:  Dean A Tripp; J Curtis Nickel; Stephanie Ross; Chris Mullins; Natalie Stechyson
Journal:  BJU Int       Date:  2008-10-24       Impact factor: 5.588

View more
  17 in total

Review 1.  Chronic Scrotal Pain.

Authors:  Christopher Wu; Keith Jarvi
Journal:  Curr Urol Rep       Date:  2018-05-31       Impact factor: 3.092

Review 2.  Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Hans C Arora; Charis Eng; Daniel A Shoskes
Journal:  Ann Transl Med       Date:  2017-01

Review 3.  Microbiota: a novel regulator of pain.

Authors:  Manon Defaye; Sandie Gervason; Christophe Altier; Jean-Yves Berthon; Denis Ardid; Edith Filaire; Frédéric Antonio Carvalho
Journal:  J Neural Transm (Vienna)       Date:  2019-09-24       Impact factor: 3.575

Review 4.  [Psychological comorbidities in patients with psychosomatic disorders of micturition].

Authors:  U Hohenfellner
Journal:  Urologe A       Date:  2016-08       Impact factor: 0.639

5.  Canadian Urological Association best practice report on chronic scrotal pain.

Authors:  Keith A Jarvi; Christopher Wu; J Curtis Nickel; Trustin Domes; John Grantmyre; Armand Zini
Journal:  Can Urol Assoc J       Date:  2018-02-23       Impact factor: 1.862

Review 6.  The relationship between the gut microbiota, benign prostatic hyperplasia, and erectile dysfunction.

Authors:  Giorgio Ivan Russo; Dafne Bongiorno; Carmelo Bonomo; Nicolò Musso; Stefania Stefani; Ioannis Sokolakis; Georgios Hatzichristodoulou; Marco Falcone; Tommaso Cai; Francesco Smarrazzo; Paolo Verze
Journal:  Int J Impot Res       Date:  2022-04-13       Impact factor: 2.896

7.  A MAPP Network Case-control Study of Urological Chronic Pelvic Pain Compared With Nonurological Pain Conditions.

Authors:  Niloofar Afari; Dedra Buchwald; Daniel Clauw; Barry Hong; Xiaoling Hou; John N Krieger; Chris Mullins; Alisa J Stephens-Shields; Marianna Gasperi; David A Williams
Journal:  Clin J Pain       Date:  2019-09-26       Impact factor: 3.423

Review 8.  Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Juan Va Franco; Tarek Turk; Jae Hung Jung; Yu-Tian Xiao; Stanislav Iakhno; Federico Ignacio Tirapegui; Virginia Garrote; Valeria Vietto
Journal:  Cochrane Database Syst Rev       Date:  2019-10-06

Review 9.  Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Juan Va Franco; Tarek Turk; Jae Hung Jung; Yu-Tian Xiao; Stanislav Iakhno; Virginia Garrote; Valeria Vietto
Journal:  Cochrane Database Syst Rev       Date:  2018-05-12

Review 10.  Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Juan Va Franco; Tarek Turk; Jae Hung Jung; Yu-Tian Xiao; Stanislav Iakhno; Virginia Garrote; Valeria Vietto
Journal:  Cochrane Database Syst Rev       Date:  2018-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.